Literature DB >> 36262930

Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis.

Wipada Laovirojjanakul1, Yosanan Yospaiboon1, Orapin Anutarapongpan1, Ajanee Mahakkanukrauh2, Siraphop Suwannaroj2, Ratanavadee Nanagara2, Chingching Foocharoen2.   

Abstract

Purpose: To evaluate the prevalence of dry eye disease (DED) in patients with both limited and diffuse subtypes of systemic sclerosis (SSc) and to determine the predictive factors associated with the occurrence of DED. Patients and
Methods: This was a prospective consecutive cross-sectional study of patients with SSc. Each patient underwent a comprehensive ophthalmological evaluation. The Ocular Surface Disease Index (OSDI) was used to assess the symptoms of DED. Tear break up time (TBUT), Schirmer I and ocular surface staining (OSS) were used for objective tests. Patients were diagnosed DED using the DEW II diagnostic method which included both symptom and objective tests. The collected data of patients with and without DED were compared to find out possible associated factors. Logistic regression analysis was used to determine the effects of these factors.
Results: Eighty-four SSc patients (25 limited and 59 diffuse subtypes) were studied. The prevalence of DED in SSc patients was 52.38%. The OSDI, tear break up time (TBUT), Schirmer I and ocular surface staining (OSS) were not significantly different between SSc subtypes. Among the 46 symptomatic patients, DED was noted in 44 (52.38%). Most patients (61.4%) were mixed aqueous deficiency-evaporative dry eye type (both TBUT and Schirmer I test positive). The mean age and the median of disease duration in DED patients were higher than those without DED with statistically significant difference (P = 0.004 and 0.019).
Conclusion: DED was common in patients with SSc. The predictors for the occurrence of DED were older age and longer disease duration. Therefore, OSDI and objective tests for DED should be evaluated in all SSc patients, particularly those with older age and longer disease duration.
© 2022 Laovirojjanakul et al.

Entities:  

Keywords:  dry eye disease; predictive factors; systemic sclerosis

Year:  2022        PMID: 36262930      PMCID: PMC9574561          DOI: 10.2147/OPTH.S387760

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


  21 in total

1.  Obtaining Lissamine Green 1% Solution for Clinical Use.

Authors:  Michael Stock; David Salvay; Bradley Shoss; Kisha Piggott; Susan M Culican
Journal:  Cornea       Date:  2015-11       Impact factor: 2.651

Review 2.  Mechanisms of skin fibrosis in systemic sclerosis.

Authors:  Masatoshi Jinnin
Journal:  J Dermatol       Date:  2010-01       Impact factor: 4.005

3.  Evaluation of dry eye signs and symptoms in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

4.  Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.

Authors:  Dinesh Khanna; Daniel E Furst; Philip J Clements; Yannick Allanore; Murray Baron; Lazlo Czirjak; Oliver Distler; Ivan Foeldvari; Masataka Kuwana; Marco Matucci-Cerinic; Maureen Mayes; Thomas Medsger; Peter A Merkel; Janet E Pope; James R Seibold; Virginia Steen; Wendy Stevens; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2017 Jan-Apr

Review 5.  Ocular manifestations of scleroderma.

Authors:  Rajen Tailor; Abha Gupta; Ariane Herrick; Jeffrey Kwartz
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

Review 6.  Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.

Authors:  S Guiducci; O Distler; J H W Distler; M Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2008-10       Impact factor: 7.580

7.  Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.

Authors:  Aniko Rentka; Annamaria Nagy; Jolan Harsfalvi; Gabriella Szucs; Zoltan Szekanecz; Rudolf Gesztelyi; Peter Szodoray; Adam Kemeny-Beke
Journal:  Rheumatol Int       Date:  2017-09-07       Impact factor: 2.631

8.  Ocular findings in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Priscilla Magalhães; Newton Kara-Junior; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Ocular manifestations in patients with systemic sclerosis.

Authors:  Małgorzata Kozikowska; Wojciech Luboń; Eugeniusz J Kucharz; Ewa Mrukwa-Kominek
Journal:  Reumatologia       Date:  2020-12-23

10.  Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity.

Authors:  Caterina Gagliano; Elisa Visalli; Mario Damiano Toro; Roberta Amato; Giovanni Panta; Davide Scollo; Giovanni Scandura; Salvatore Ficili; Giorgio Amato; Alessia Benenati; Roberta Foti; Giulia Malaguarnera; Giuseppe Gagliano; Raffaele Falsaperla; Teresio Avitabile; Rosario Foti
Journal:  Diagnostics (Basel)       Date:  2020-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.